Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnathan D Guest

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Nature Communications|July 5, 2023
Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodiesMatthew C Metcalf, Benjamin M Janus, Rui Yin, et al.
Vaccines|August 28, 2025
SARS-CoV-2 RBD Scaffolded by AP205 or TIP60 Nanoparticles and Delivered as mRNA Elicits Robust Neutralizing Antibody ResponsesJohnathan D Guest, Yi Zhang, Daniel Flores, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.
Journal of Virology|January 18, 2019
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect CellsRichard A Urbanowicz, Ruixue Wang, John E Schiel, et al.
Plos Pathogens|May 18, 2019
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine designZhen-Yong Keck, Brian G Pierce, Patrick Lau, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerJohnathan D Guest, Ruixue Wang, Khadija H Elkholy, et al.
Gastroenterology|October 16, 2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine DevelopmentJordan H Salas, Richard A Urbanowicz, Johnathan D Guest, et al.
Nature Communications|July 19, 2023
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsBahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIVMohammad M Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nature Communications|July 5, 2023
Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodiesMatthew C Metcalf, Benjamin M Janus, Rui Yin, et al.
Vaccines|August 28, 2025
SARS-CoV-2 RBD Scaffolded by AP205 or TIP60 Nanoparticles and Delivered as mRNA Elicits Robust Neutralizing Antibody ResponsesJohnathan D Guest, Yi Zhang, Daniel Flores, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.
Journal of Virology|January 18, 2019
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect CellsRichard A Urbanowicz, Ruixue Wang, John E Schiel, et al.
Plos Pathogens|May 18, 2019
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine designZhen-Yong Keck, Brian G Pierce, Patrick Lau, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerJohnathan D Guest, Ruixue Wang, Khadija H Elkholy, et al.
Gastroenterology|October 16, 2021
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine DevelopmentJordan H Salas, Richard A Urbanowicz, Johnathan D Guest, et al.
Nature Communications|July 19, 2023
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsBahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIVMohammad M Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
Pageof 3